239
Views
20
CrossRef citations to date
0
Altmetric
Research Articles

Spray-dried solid dispersions containing ferulic acid: comparative analysis of three carriers, in vitro dissolution, antioxidant potential and in vivo anti-platelet effect

, , , , , , & show all
Pages 1813-1824 | Received 13 Jan 2016, Accepted 28 Mar 2016, Published online: 24 Apr 2016

References

  • Savjani KT, Gajjar AK, Savjani JK. Drug solubility: importance and enhancement techniques. ISRN Pharm 2012;2012:1–10.
  • Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 2000;50:47–60.
  • Vasconcelos T, Sarmento B, Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov Today 2007;12:1068–75.
  • Dhillon B, Goyal NK, Malviya R, Sharma PK. Poorly water soluble drugs: change in solubility for improved dissolution characteristics: a review. Global J Pharmacol 2014;8:26–35.
  • Huang Y, Dai W-G. Fundamental aspects of solid dispersion technology for poorly soluble drugs. Acta Pharm Sin B 2014;4:18–25.
  • Van den Mooter G, Augustijns P, Blaton N. Physicochemical characterization of solid dispersions of temazepam with polyethylene glycol 6000 and PVP K30. Int J Pharm 1998;164:67–80.
  • Patel DB. Comparative evaluation of different carriers to enhance solubility and dissolution of poor water soluble drug. Int J Pharm Bio Sci 2014;5:463–71.
  • Chen Y, Zhang GG, Neilly J. Enhancing the bioavailability of ABT-963 using solid dispersion containing Pluronic F-68. Int J Pharm 2004;286:69–80.
  • Vyas V, Sancheti P, Karekar P. Physicochemical characterization of solid dispersion systems of tadalafil with poloxamer 407. Acta Pharm 2009;59:453–61.
  • Senthilkumar KL, Sirisha Y. Enhancement of dissolution rate studies on solid dispersion of aceclofenac. Int J Pharm Bio Sci 2011;2:70–6.
  • Wang J, Cao Y, Sun B, Wang C. Characterization of inclusion complex of trans-ferulic and hydroxypropyl-beta-cyclodextrin. Food Chem 2011;124:1069–75.
  • Itagaki S, Kurokawa T, Nakata C, et al. In vitro and in vivo antioxidant properties of ferulic acid: a comparative study with other natural oxidation inhibitors. Food Chem 2009;114:466–71.
  • Murakami A, Nakamura Y, Koshimizu K, et al. FA15, a hydrophobic derivative of ferulic acid, suppresses inflammatory responses and skin tumor promotion: comparison with ferulic acid. Cancer Lett 2002;180:121–9.
  • Ou S, Kwok K-C. Ferulic acid: pharmaceutical functions, preparation and application. J Sci Food Agr 2004;84:1261–9.
  • Soobrattee MA, Neergheen VS, Luximon-Ramma A, et al. Phenolics as potential antioxidant therapeutic agents: mechanism and actions. Mutat Res 2005;579:200–13.
  • Merlin JPJ, Prasad NR, Shibli SMA, Sebeela M. Ferulic acid loaded Poly-d,l-lactide-co-glycolide nanoparticles: systematic study of particle size, drug encapsulation efficiency and anticancer effect in non-small cell lung carcinoma cell line in vitro. Biomed Prev Nutr 2012;2:69–76.
  • Anselmi C, Centini M, Ricci M, et al. Analytical characterization of a ferulic acid/gamma-cyclodextrin inclusion complex. J Pharm Biomed Anal 2006;40:875–81.
  • Anselmi C, Centini M, Maggiore M, et al. Non-covalent inclusion of ferulic acid with alpha-cyclodextrin improves photo-stability and delivery: NMR and modeling studies. J Pharm Biomed Anal 2008;46:645–52.
  • Yu D-G, Yang J-M, Branford-White C, et al. Third generation solid dispersions of ferulic acid in electrospun composite nanofibers. Int J Pharm 2010;400:158–64.
  • Paradkar A, Ambike AA, Jadhav BK, Mahadik KR. Characterization of curcumin-PVP solid dispersion obtained by spray drying. Int J Pharm 2004;271:281–6.
  • Weuts I, Kempen D, Verreck G, et al. Study of the physicochemical properties and stability of solid dispersions of loperamide and PEG6000 prepared by spray drying. Eur J Pharm Biopharm 2005;59:119–26.
  • ICH Q2 (R1). Validation of analytical procedures: Text and Methodology 2005;4:1--13
  • Nadal JM, Toledo MG, Pupo YM, et al. A stability-indicating HPLC-DAD method for determination of ferulic acid into microparticles: development, validation, forced degradation, and encapsulation efficiency. J Anal Methods Chem 2015;2015:1–10.
  • Khan KA. The concept of dissolution efficiency. J Pharm Pharmacol 1975;27:48–9.
  • Freitag G. Guidelines on dissolution profile comparison. Drug Inf J 2001;35:865–74.
  • Beck RCR, Pohlmann AR, Benvenutti EV, et al. Nanostructure-coated diclofenac-loaded microparticles: preparation, morphological characterization, in vitro release and in vivo gastrointestinal tolerance. J Braz Chem Soc 2005;16:1233–40.
  • Re R, Pellegrini N, Proteggente A, et al. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med 1999;26:1231–7.
  • Chan S-Y, Chung Y-Y, Cheah X-Z, et al. The characterization and dissolution performances of spray dried solid dispersion of ketoprofen in hydrophilic carriers. AJPS 2015;10:372–85.
  • Singh S, Dixit D. A Review on spray drying: emerging technology in food industry. IJAET 2014;4:1–8.
  • Jørgensen AC, Torstenson AS. Humid storage conditions increase the dissolution rate of diazepam from solid dispersions prepared by melt agglomeration. Pharm Dev Technol 2008;13:187–95.
  • Kanaujia P, Lau G, Ng WK, et al. Investigating the effect of moisture protection on solid-state stability and dissolution of fenofibrate and ketoconazole solid dispersions using PXRD, HSDSC and Raman microscopy. Drug Dev Ind Pharm 2011;37:1026–35.
  • Callahan JC, Cleary GW, Elefant M, et al. Equilibrium moisture content of pharmaceutical excipients. Drug Dev Ind Pharm 1982;8:355–69.
  • Saija A, Tomaino A, Trombetta D, et al. In vitro and in vivo evaluation of caffeic and ferulic acids as topical photoprotective agents. Int J Pharm 2000;199:39–47.
  • Murtaza G, Khan SA, Najam-ul-Haq M, Hussain I. Comparative evaluation of various solubility enhancement strategies for furosemide. Pak J Pharm Sci 2014;27:963–73.
  • Ohara T, Kitamura S, Kitagawa T, Terada K. Dissolution mechanism of poorly water-soluble drug from extended release solid dispersion system with ethylcellulose and hydroxypropylmethylcellulose. Int J Pharm 2005;302:95–102.
  • Kabanov KV, Batrakova EV, Alakhov VY. Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. J Control Release 2002;82:189–212.
  • Jones MC, Leroux JC. Polymeric micelles – a new generation of colloidal drug carriers. Eur J Pharm Biopharm 1999;48:101–11.
  • Sharma A, Jain CP. Preparation and characterization of solid dispersions of carvedilol with PVP K30. Res Pharm Sci 2010;5:49–56.
  • Newman A. Pharmaceutical amorphous solid dispersions. New York: Wiley; 2015.
  • Guedes FL, de Oliveira BG, Hernandes MZ, et al. Solid dispersions of imidazolidinedione by PEG and PVP polymers with potential antischistosomal activities. AAPS PharmSciTech 2011;12:401–10.
  • Bhise SD. Ternary solid dispersions of fenofibrate with poloxamer 188 and TPGS for enhancement of solubility and bioavailability. IJRPBS 2011;2:583–95.
  • Brittain HB. X-ray powder diffraction of pharmaceutical materials. Am Pharmaceut Rev 2002;5:74–80.
  • Bogdanova S, Pajeva I, Nikolova P, et al. Interactions of poly (vinylpyrrolidone) with ibuprofen and naproxen: experimental and modeling studies. Pharm Res 2005;22:806–15.
  • Frizon F, Eloy JO, Donaduzzi CM, et al. Dissolution rate enhancement of loratadine in polyvinylpyrrolidone K-30 solid dispersions by solvent methods. Powder Technol 2013;235:532–9.
  • Hatakeyama T, Quinn F X. Thermal analysis; fundamentals and applications to polymer science. New York: Wiley; 1994.
  • Pielichowski K, Njuguna J. Thermal degradation of polymeric materials. Shrewsbury: RAPRA; 2005.
  • Chen Y, Liu C, Chen Z, et al. Drug − polymer − water interaction and its implication for the dissolution performance of amorphous solid dispersions. Mol Pharmaceutics 2015;12:576–89.
  • Kalia A, Khurana S, Bedi N. Formulation and evaluation of mouth dissolving tablets of oxcarbazepine. Int J Pharm Pharm Sci 2009;1:12–23.
  • Raffin RP, Colomé LM, Pohlmann AR, Guterres SS. Preparation, characterization, and in vivo anti-ulcer evaluation of pantoprazole-loaded microparticles. Eur J Pharm Biopharm 2006;63:198–204.
  • Mendes JBE, Riekes MK, de Oliveira VM, et al. PHBV/PCL microparticles for controlled release of resveratrol: physicochemical characterization, antioxidant potential, and effect on hemolysis of human erythrocytes. ScientificWorldJournal 2012;2012:1–13.
  • Ruiz ME, Volonté MG. Biopharmaceutical relevance of dissolution profile comparison: proposal of a combined approach. Dissolut Technol 2014;21:32–43.
  • Peng H, Xiong H, Li J, et al. Vanillin cross-linked chitosan microspheres for controlled release of resveratrol. Food Chem 2010;121:23–8.
  • Patel N, Chotai N, Patel J, et al. Comparison of in vitro dissolution profiles of oxcarbazepine-HP β-CD tablet formulations with marketed oxcarbazepine tablets. Dissolut Technol 2008;15:28–34.
  • Wilkowska A, Ambroziak W, Czyżowska A, Adamiec J. Effect of microencapsulation by spray-drying and freeze-drying technique on the antioxidant properties of blueberry (Vaccinium myrtillus) juice polyphenolic compounds. Pol J Food Nutr Sci 2016;66:11–16.
  • Steinhubl SR, Berger PB, Mann IIIJT. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002;288:2411–20.
  • Zhang P-X, Lin H, Qu C, et al. Design, synthesis, and in vitro antiplatelet aggregation activities of ferulic acid derivatives. J Chem 2015;2015:1–7.
  • Schrör K. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis. Semin Thromb Hemost 1997;23:349–56.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.